An Accord for a Healthier World Expands

Pfizer Inc. today announced that it has significantly expanded its commitment to An Accord for a Healthier World to offer the full portfolio of medicines and vaccines for which it has global rights on a not-for-profit basis to enable greater health for 1.2 billion people living in 45 lower-income countries.

To better align with disease burden and unmet patient needs in these countries, Pfizer is expanding its offering under the Accord to include off-patent products, bringing the total offering to around 500 products.

Launched in May 2022, the Accord is a transformative initiative focused on reducing health inequities.

The Accord initially included a commitment from Pfizer for access to all its patented medicines and vaccines available in the U.S. or European Union on a not-for-profit basis to 45 lower-income countries.

The Accord portfolio offering now includes chemotherapies and oral cancer treatments that can potentially treat nearly one million new cancer cases in Accord countries each year.

It also includes a wide range of antibiotics that can help to address the rising morbidity, mortality, and costs associated with antimicrobial resistance. 

As Pfizer launches new medicines and vaccines, those products will also be included in the Accord portfolio on a not-for-profit basis.

“We launched the Accord to help reduce the glaring health equity gap that exists in our world. Our hope is to empower country governments and co-create solutions with them and other multi-sector partners to break down many of the system-level barriers to better health. In the months since the Accord’s launch, we have heard resoundingly from these leaders that access to a broader and more immediate scope of consistent, high-quality products is needed for meaningful and sustainable transformation. We believe this expansion of our product offering, combined with continued efforts to help address the barriers that limit or prevent access, will help us to achieve and even expedite our vision of a world where all people have access to the medicines and vaccines they need to live longer and healthier lives,” said Pfizer Chairman and CEO Albert Bourla, in a press release on January 17, 2023.

Alongside governments and multi-sector partners, Pfizer is working to co-create scalable solutions that help address systemic barriers to better health focused on finding faster, more efficient pathways for the supply of medicines and vaccines as well as strengthening the resources, capabilities, and platforms that can enable quick and more sustainable access to those medicines.

This includes technical expertise, training, diagnostic capacity, innovative financing, and more.

“The Accord is an important step toward sustainable health security for Rwanda and the broader continent. The expanded portfolio offering and public health system strengthening efforts will further enhance our progress and offer valuable support to key national health initiatives that lead to positive health outcomes,” commented His Excellency Paul Kagame, President of Rwanda.

Further details about An Accord for a Healthier World are available at Pfizer.com/Accord.